At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
09966 ALPHAMAB-B
Not Yet Opened 10-16 16:08:16
6.900
+0.225
+3.37%
High7.180Low6.810Vol1.04M
Open6.810D1 Closing6.675Amplitude5.54%
Mkt Cap6.67BTradable Cap6.67BTotal Shares966.00M
T/O7.28MT/O Rate0.11%Tradable Shares966.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Alphamab Oncology Executes HKD 0.94 Million Share Buyback, Lifts Treasury Stock to 8.09 Million Shares
Bulletin Express  ·  10-15
Alphamab Oncology Executes HKD 0.94 Million Share Buyback, Lifts Treasury Stock to 8.09 Million Shares
Alphamab Oncology Buys Back 0.14 Million Shares, Treasury Stock Rises to 7.95 Million
Bulletin Express  ·  10-14
Alphamab Oncology Buys Back 0.14 Million Shares, Treasury Stock Rises to 7.95 Million
ALPHAMAB-B (09966) Spends HK$974,900 to Buy Back 140,000 Shares on October 14
Stock News  ·  10-14
ALPHAMAB-B (09966) Spends HK$974,900 to Buy Back 140,000 Shares on October 14
Alphamab Oncology Repurchases 1.82 Million Shares in September; Public Float Remains Intact
Bulletin Express  ·  10-05
Alphamab Oncology Repurchases 1.82 Million Shares in September; Public Float Remains Intact
ALPHAMAB-B (09966) Repurchases 58,000 Shares for HK$465,000 on September 28
Stock News  ·  09-28
ALPHAMAB-B (09966) Repurchases 58,000 Shares for HK$465,000 on September 28
ALPHAMAB-B (09966) Spends HK$290,300 to Repurchase 35,000 Shares on September 25
Stock News  ·  09-25
ALPHAMAB-B (09966) Spends HK$290,300 to Repurchase 35,000 Shares on September 25
ALPHAMAB-B Buys Back 35,000 Shares, Lifts Treasury Stock to 7.75 Million
Bulletin Express  ·  09-25
ALPHAMAB-B Buys Back 35,000 Shares, Lifts Treasury Stock to 7.75 Million
Alphamab Oncology Adds 122,000 Shares to Treasury, Utilising 1.52% of Buy-Back Mandate
Bulletin Express  ·  09-15
Alphamab Oncology Adds 122,000 Shares to Treasury, Utilising 1.52% of Buy-Back Mandate
Alphamab Oncology-B Completes Share Buyback Worth Approximately HK$967,000
Stock News  ·  09-15
Alphamab Oncology-B Completes Share Buyback Worth Approximately HK$967,000
ALPHAMAB-B (09966) Allocates Approximately HK$796,300 for Share Buyback on September 14
Stock News  ·  09-14
ALPHAMAB-B (09966) Allocates Approximately HK$796,300 for Share Buyback on September 14
ALPHAMAB-B Buys Back 99,000 Shares; Treasury Stock Climbs to 7.22 Million
Bulletin Express  ·  09-14
ALPHAMAB-B Buys Back 99,000 Shares; Treasury Stock Climbs to 7.22 Million
Alphamab-B Buys Back 123,000 Shares for HK$0.98 Million, Treasury Stock Rises to 7.12 Million
Bulletin Express  ·  09-11
Alphamab-B Buys Back 123,000 Shares for HK$0.98 Million, Treasury Stock Rises to 7.12 Million
Alphamab Oncology Buys Back 164,000 Shares at HKD 8.28 Each, Treasury Stock Rises to 6.99 Million
Bulletin Express  ·  09-10
Alphamab Oncology Buys Back 164,000 Shares at HKD 8.28 Each, Treasury Stock Rises to 6.99 Million
Alphamab Oncology Files HKEX Next-Day Return Disclosing Share Buyback at HKD 8.28 Each
Reuters  ·  09-10
Alphamab Oncology Files HKEX Next-Day Return Disclosing Share Buyback at HKD 8.28 Each
Alphamab Oncology repurchases 0.12 million shares for HK$0.99 million, expands treasury stock to 6.83 million
Bulletin Express  ·  09-09
Alphamab Oncology repurchases 0.12 million shares for HK$0.99 million, expands treasury stock to 6.83 million
Alphamab Oncology Buys Back 220,000 Shares for HKD 1.85 Million, Treasury Stock Climbs to 6.72 Million
Bulletin Express  ·  09-08
Alphamab Oncology Buys Back 220,000 Shares for HKD 1.85 Million, Treasury Stock Climbs to 6.72 Million
Alphamab-B Repurchases 220,000 Shares for HK$1.85 Million on September 8
Stock News  ·  09-08
Alphamab-B Repurchases 220,000 Shares for HK$1.85 Million on September 8
Alphamab Oncology Files HKEX Next-Day Return Disclosing Share Repurchase at HKD 8.41
Reuters  ·  09-08
Alphamab Oncology Files HKEX Next-Day Return Disclosing Share Repurchase at HKD 8.41
ALPHAMAB-B Repurchases 115,000 Shares for HK$989,200 on September 7
Stock News  ·  09-07
ALPHAMAB-B Repurchases 115,000 Shares for HK$989,200 on September 7
Alphamab Oncology Files HKEX Next-Day Return Disclosing Share Repurchase at HKD 8.6 Each
Reuters  ·  09-07
Alphamab Oncology Files HKEX Next-Day Return Disclosing Share Repurchase at HKD 8.6 Each
No data available

Introduction

Company Name.
ALPHAMAB-B
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
Alphamab Oncology is an investment holding company principally engaged in research and development, manufacturing and commercialisation of biologics of oncology. The Company’s in-house pipeline consists of antibody-drug conjugates (ADCs), monoclonal antibodies and bispecific antibodies in staggered development status in oncology. The Company’s product pipeline includes KN046 (PD-L1/CTLA-4 bispecific antibody), KN026 (HER2/HER2 bispecific antibody), KN035 (SubQ PD-L1), JSKN003 (HER2 biparatopic ADC), JSKN016(HER3/TROP2 bispecific antibody ADC), JSKN033(subcutaneous co-formulation of JSKN003 and KN035), used for indications such as 1L sq NSCLC, 1L HER2+ BC, 1L biliary track cancer, advanced solid tumors, HER2-expressing solid tumors and others.
Issue price:
--